BIOPHARMCOR..ADVANCING MEN’S HEALTH
Through the development of safe and effective physician prescribed generic drug therapies for the treatment of chronic male disorders including Erectile Dysfunction (ED) and Benign Prostatic Hyperplasia (BPH)
ARGUS WORLDWIDE CORP. ACQUIRES CONTROL BLOCK OF EARLY STAGE GENERIC PHARMACEUTICAL FIRM BIOPHARMCOR BV
Ottawa, Ontario October 19, 2017: The Board of Directors of Argus Worldwide Corp. (www.argusworldwide.com) and VMS Rehab Systems, Inc. (www.vmsrehabsystemsinc.com) jointly report on the completion of a Share Transfer Agreement signed on March 30th, 2017. The Share Transfer Agreement supersedes a proposed transaction that was tentatively agreed between the Parties in late 2016. Under the terms of the new agreement signed on March 29th, 2017, VMS has agreed to transfer to Argus a control block of 17,005,000 Class A ordinary voting shares and 55,000 Class B multiple voting shares of... More
BioPharmcor: Generic Solutions Advancing Men’s Health
The rising costs of healthcare are causing governments and health payers throughout the world to develop affordable solutions for pharmaceutical care and carefully review the sustainability of their healthcare programs. The way we see it, the most efficient and cost effective solution for containing the high cost of providing optimum medical care is through a substantial increase in the use of generic medicines.
More useful info